PIK3CA-related overgrowth spectrum
Log in to starLast updated Nov 3, 2026
A child has asymmetric overgrowth affecting one leg with vascular malformations and epidermal nevi. Tissue biopsy reveals a somatic PIK3CA variant.
Somatic (mosaic); PIK3CA, encoding p110alpha, the catalytic subunit of phosphatidylinositol-3-kinase (PI3K). Usually postzygotic activating (gain-of-function) missense variants.
- Includes: CLOVES, Klippel-Trenaunay, megalencephaly-capillary malformation
PI3K carries the signals of insulin and insulin-like growth factor 1 through downstream effectors such as AKT and mTOR. PROS variants hyperactivate this pathway, which drives abnormal growth of the tissues that carry them and vascular malformations. The activated kinase may also mimic insulin, which may explain hyperinsulinism-like features in some infants with a high variant burden.
The variants arise after conception, so only some cells carry them, and the level of mosaicism in affected tissue varies widely. Hot-spot variants (p.Glu542Lys, p.Glu545Lys, p.His1047Arg, p.His1047Lys), the same ones found in many cancers, go with the more focal phenotypes: CLOVES syndrome, fibroadipose hyperplasia, vascular malformations, and hemimegalencephaly, with more severe epilepsy when in the brain. Analysis suggests that MCAP syndrome is mainly associated with a wider range of variants spread across the gene.
Mosaicism shapes testing: the variant has been found in blood only rarely (2 of 24 people with MCAP, who had germline variants), so blood testing is not recommended and affected tissue is tested. Alpelisib, a PI3K inhibitor, acts on the overactive enzyme and is approved to reduce overgrowth and vascular lesions.
- Segmental/asymmetric overgrowth
- Vascular malformations
- Epidermal nevi
- Variable features depending on timing and tissue distribution
- Recognize the clinical overgrowth pattern (segmental/asymmetric, vascular malformations, lipomatous overgrowth, megalencephaly)
- Confirm with sequencing of affected (lesional) tissue; the somatic PIK3CA variant is often undetectable in blood, so a biopsy of affected tissue with high-sensitivity (deep) sequencing is preferred
- Imaging to map extent of overgrowth and vascular malformations (MRI/MRV); echocardiography if megalencephaly-capillary malformation (cardiac involvement)
- Multidisciplinary care coordinated by overgrowth and vascular anomaly specialists
- Alpelisib (PI3K pathway inhibitor) for severe or refractory PIK3CA-related overgrowth
- Orthopedic management of limb-length discrepancy; interventional/surgical treatment of symptomatic vascular malformations; anticoagulation/thrombosis risk monitoring with extensive venous malformations
- Recurrence risk is low (postzygotic mosaicism); no increased risk to future offspring or siblings in most cases